Short reports and Correspondence| Volume 60, ISSUE 12, P1357-1360, December 2007

The sleeper cells: delayed sentinel lymph node biopsy

Published:September 10, 2007DOI:
      The sentinel lymph node biopsy (SLNB) was introduced in 1992 by Morton et al.,
      • Morton D.L.
      • Wen D.R.
      • Wong J.H.
      • et al.
      Technical details of intra-operative lymphatic mapping for early stage melanoma.
      and is defined as the procedure of identifying and removing the first draining node in the lymphatic pathway from the primary tumour site.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Morton D.L.
        • Wen D.R.
        • Wong J.H.
        • et al.
        Technical details of intra-operative lymphatic mapping for early stage melanoma.
        Arch Surg. 1992; 127: 392-399
        • Gershenwald J.E.
        • Thompson W.
        • Mansfield P.F.
        • et al.
        Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
        J Clin Oncol. 1999; 17: 976-983
        • Kettlewell S.
        • Moyes C.
        • Bray C.
        • et al.
        Value of sentinel node status as a prognostic factor in melanoma: prospective observational study.
        BMJ. 2006; 332: 1423
        • Balch C.M.
        • Buzaid A.C.
        • Soong S.J.
        • et al.
        Final version of the American Joint committee on Cancer staging system for cutaneous melanoma.
        J Clin Oncol. 2001; 19: 3635-3648
        • Eisen T.
        A study to investigate the diagnosis and treatment of melanoma skin cancer with sentinel lymph node biopsy. Cancer Research UK.
        • Leong S.P.L.
        • Thelmo M.C.
        • Kim R.P.
        • et al.
        Delayed harvesting of sentinel lymph nodes after previous wide local excision of extremity melanoma.
        Ann Surg Oncol. 2003; 10: 196-200
        • Kelemen P.R.
        • Essner R.
        • Foshag L.J.
        • et al.
        Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma.
        J Am Coll Surg. 1999; 189: 247-252
        • Uren R.
        • Howman-Giles R.
        • Thompson J.F.
        Patterns of lymphatic drainage from the skin in patients with melanoma.
        J Nucl Med. 2003; 44: 570-582
        • Morton D.L.
        • Hoon D.S.B.
        • Cochran A.J.
        • et al.
        Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma.
        Ann Surg. 2003; 238: 538-550
        • Braun S.
        • Cevatli B.S.
        • Assemi C.
        • et al.
        Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
        J Clin Oncol. 2001; 19: 1468-1475
        • Fisher B.
        • Fisher E.R.
        Transmigration of lymph nodes by tumour cells.
        Science. 1966; 152: 1397-1398
        • Thompson J.F.
        • Stretch J.R.
        • Uren R.F.
        • et al.
        Sentinel node biopsy for melanoma: where have we been and where are we going?.
        Ann Surg Oncol. 2004; 11: 147S-151S
        • Morton D.L.
        • Thompson J.F.
        • Cochran A.J.
        • et al.
        Interim results of the multicenter selective lymphadenectomy trial (MSLT-I) in clinical stage I melanoma.
        J Clin Oncol. 2005; 23 (abstract 7500): 16S
        • van Akkooi A.C.
        • de Wilt J.H.
        • Verhoef C.
        • et al.
        Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes; are these nodes to be considered negative?.
        Ann Oncol. 2006 Oct; 17: 1578-1585